A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Public ClinicalTrials.gov record NCT00902928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of various doses of YM150 (the experimental drug) compared to enoxaparin in the prevention of venous thromboembolism in patients that are undergoing elective hip replacement surgery.
Study identification
- NCT ID
- NCT00902928
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 1,992 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- May 31, 2010
- Completion
- Jul 31, 2010
- Last update posted
- Oct 26, 2015
2009 – 2010
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Phoenix | Arizona | 85050 | — |
| Not listed | Tuscon | Arizona | 85712 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | Torrance | California | 90507 | — |
| Not listed | Aurora | Colorado | 80015 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | Tamarac | Florida | 33321 | — |
| Not listed | Meridian | Idaho | 83642 | — |
| Not listed | Lexington | Kentucky | 40509 | — |
| Not listed | Baltimore | Maryland | 21215 | — |
| Not listed | Charleston | South Carolina | 29414 | — |
| Not listed | Austin | Texas | 78745 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 138 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00902928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2015 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00902928 live on ClinicalTrials.gov.